WHO ICTRP trial
A Clinical Trial to study the Safety, Tolerability and Effect of Tocilizumab in…
CTRI/2009/091/000402 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/000402 |
|---|---|
| Public title | A Clinical Trial to study the Safety, Tolerability and Effect of Tocilizumab in Patients with Active Rheumatoid Arthritis taking Background Non-biologic DMARDs and having an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy |
| Scientific title | Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy - ACTSURE |
| Primary sponsor | Roche Products India Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Belgium;Denmark;Germany;Ireland;Luxembourg;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Sweden;Switzerland;Turkey;United Kingdom |
| Conditions | Health Condition 1: null- Active Rheumatoid Arthritis |
| Interventions | Intervention1: Tocilizumab: 8 mg/kg of body weight every 4 weeks for a total of 6 infusions Control Intervention1: NIL: NIL |
| Registration date | Jul 1, 2011 |
| Target size | 1500 |
| Secondary IDs | MA21573 version 3.0 dated 04 Nov 2008;NCT00750880 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: